Gastrointestinal CRO Services for Complex Clinical Trials
Advance gastrointestinal clinical trials with an integrated CRO and eClinical technology partner built for endpoint sensitivity, operational clarity, and efficient execution across complex GI programs.
Sitero supports sponsors across inflammatory bowel disease, irritable bowel syndrome, NASH/MASH, GERD, celiac disease, hepatology programs, and rare GI disorders with full-service clinical trial delivery and integrated technology.
Gastrointestinal studies require close coordination across symptom-based endpoints, biomarkers, endoscopy, imaging, procedure-based visits, and patient retention. Sitero helps reduce fragmentation across sites, vendors, and study workflows.
Built for Gastrointestinal Trial Complexity
Gastrointestinal trials require consistent endpoint execution, specialized site workflows, thoughtful patient support, and clear coordination across operational and data functions. Sitero helps sponsors manage that complexity with coordinated services and connected technology.
Common gastrointestinal trial challenges include:
Clinical Trial Technology that Supports Execution
Sitero’s delivery model is supported by a broad eClinical ecosystem, including:
Mentor EDC
Integration advantage
EDC updates stay aligned with operations and data management, maintaining consistency across protocol changes, visit schedules, and endpoint workflow
Mentor RTSM
Integration advantage
RTSM and EDC integration reduces handoff risk across eligibility, treatment assignment, stratification (e.g., prior biologic exposure, disease severity), and visit workflows.
Mentor Site and Participant Payments
Integration advantage
Connected payment workflows can reduce site burden and improve sponsor visibility into payment status.
Mentor eConsent
Integration advantage
Real-time consent tracking enables faster response to version updates, procedural requirements, and re-consent needs.
Mentor CTMS and eTMF
Integration advantage
Connected workflows allow sponsors to track site readiness, training, activation timelines, and inspection readiness in one system.
Mentor Insights and Reporting
Integration advantage
Centralized reporting helps teams identify PRO compliance gaps, enrollment trends, procedure risks, visit deviations, and site performance earlier to support faster decisions.
Gastrointestinal CRO Services
Sitero supports complex gastrointestinal studies across IBD, IBS, hepatology, NASH/MASH, GERD, celiac disease, and rare GI conditions with integrated clinical operations, biometrics, safety, ethics, and medical writing support.
Clinical Operations for GI Studies
Sitero supports complex GI studies across IBD, IBS, hepatology, NASH/MASH, GERD, celiac disease, and rare conditions with integrated clinical operations, biometrics, safety, ethics, and medical writing.
Biometrics for Endpoint Quality
Biometrics and data management support database design, edit checks, centralized review, programming, and analysis-ready datasets. The team supports symptom-based endpoints, eDiary compliance, biomarker integration, and endoscopic and histologic reads, with early identification of data anomalies.
Medical Monitoring and Scientific Oversight
Sitero provides medical oversight for safety review, eligibility, protocol interpretation, and issue escalation. Cross-functional reviews align teams on enrollment quality, protocol deviations, endpoint interpretability, and patient safety.
Drug Safety and Pharmacovigilance Support
Sitero supports safety operations across GI therapies, biologics, devices, and advanced modalities, including monitoring hepatic events, GI tolerability, infection risk, and long-term safety.
IRB, Ethics, and Governance Support
Sitero supports ethics and governance workflows, including IRB and IEC submissions, consent updates, amendments, and country-specific requirements for GI studies.
Dedicated ethics specialists help sponsors navigate complex biopsy procedures, long-term follow-up, and safety-driven amendments so approvals, consent versions, and site communications stay aligned.
Medical Writing for Gastrointestinal Programs
The medical writing team supports protocols, informed consent, study reports, regulatory documents, and trial communications.
Sitero Key Metrics
Integrated Workflows for Lower Site Burden and Clearer Oversight
Gastrointestinal trials require coordination across operations, endpoints, biomarkers, endoscopy, safety, and site support. Sitero helps create a more connected model that lowers site burden and improves sponsor visibility.
Global Support for Gastrointestinal Programs
Sitero supports global clinical trial services and technology-enabled execution across study models. For GI programs, teams help coordinate the operational, regulatory, data, and site details that shape trial performance.
Why Sponsors Choose Sitero for Gastrointestinal Trials
Sponsors typically select Sitero when they need:
Integrated CRO services and technology in one model
Clear ownership across startup, conduct, data, safety, and closeout
Broad functional support for endpoint-sensitive, operationally complex GI studies.
Global execution without added complexity
Cross-functional oversight that helps teams act earlier on enrollment, quality, and endpoint risks.
FAQs
Yes. Sitero helps sponsors manage recurring assessments, diary completion, follow-up procedures, patient engagement, and retention workflows throughout the study.
Yes. Sitero supports pharmacovigilance and safety operations for gastrointestinal studies, including programs with complex hepatic, immunologic, and long-term safety monitoring.
Sitero supports endpoint quality through database design, data review workflows, monitoring, biometrics support, and coordinated oversight for repeated symptom, biomarker, and procedural assessments.
Yes. Mentor eClinical Technology supports eConsent, data capture, and reporting for gastrointestinal studies in one connected environment.
Sponsors should look for a partner with experience in endpoint sensitivity, patient-reported outcomes, endoscopic workflows, recruitment complexity, and GI safety monitoring.
Yes. Sitero supports sponsors across IBD, IBS, NASH/MASH, GERD, celiac disease, hepatology programs, and rare GI disorders.
